Abstract |
Currently, effective and specific diagnostic imaging of brain glioma is a major challenge. Nanomedicine plays an essential role by delivering the contrast agent in a targeted manner to specific tumor cells, leading to improvement in accurate diagnosis by good visualization and specific demonstration of tumor cells. This study investigated the preparation and characterization of a targeted MR contrast agent, transferrin-conjugated superparamagnetic iron oxide nanoparticles (Tf-SPIONs), for brain glioma detection. MR imaging showed the obvious contrast change of brain glioma before and after administration of Tf-SPIONs in C6 glioma rat model in vivo on T2 weighted imaging. Significant contrast enhancement of brain glioma could still be clearly seen even 48 h post injection, due to the retention of Tf-SPIONs in cytoplasm of tumor cells which was proved by Prussian blue staining. Thus, these results suggest that Tf-SPIONs could be a potential targeting MR contrast agent for the brain glioma.
|
Authors | Weili Jiang, Hui Xie, Devina Ghoorah, Yalei Shang, Haojun Shi, Fang Liu, Xiangliang Yang, Haibo Xu |
Journal | PloS one
(PLoS One)
Vol. 7
Issue 5
Pg. e37376
( 2012)
ISSN: 1932-6203 [Electronic] United States |
PMID | 22615995
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Contrast Media
- Dextrans
- Ferric Compounds
- Magnetite Nanoparticles
- Transferrin
- ferric oxide
- ferumoxides
|
Topics |
- Animals
- Brain Neoplasms
(diagnosis)
- Contrast Media
(administration & dosage)
- Dextrans
- Ferric Compounds
- Glioma
(diagnosis)
- Magnetic Resonance Imaging
(methods)
- Magnetite Nanoparticles
- Male
- Neuroimaging
(methods)
- Rats
- Rats, Wistar
- Transferrin
|